Articles

Roths may be overrated for most investors, new research suggests.

A top U.K. government official told Parliament he can’t afford a subscription to Bloomberg News.

UBS stock reached a new 16-year high after the Wall Street Journal said the bank is about to get fined hundreds of millions of dollars.

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

An analyst sees big upside ahead, fueled by rapid growth in high-bandwidth memory for AI.

Rising unemployment prodded the Federal Reserve to cut interest rates last fall despite lingering inflation — and the jobless rate could still be the deciding factor for future rate cuts.

The U.S. labor market remains healthy and the Federal Reserve can take a gradual and patient approach to future rate cuts, Boston Fed President Susan Collins said Thursday.

Treasury yields drift lower on Thursday to start of an abbreviated session, with the bond market set to shut early in observance of a national day of mourning in honor of former President Jimmy Carter, who died in late December.

One human-rights group called Meta’s fact-checking change “exceedingly dangerous.” That didn’t seem to stop the company.

Retired public workers will get check adjustments and retro pay under the recently signed Social Security Fairness Act.

“My in-laws are coming to watch our 7-year-old daughter and her 2-year-old sister.”

Cybersecurity threats are no longer occasional, isolated incidents but a relentless, daily battle.